Scabies Treatment: Comparing Permethrin Creams

We are testing whether a new 10% permethrin cream works better than the standard 5% cream for treating scabies. We will also look at the safety of the new cream.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Infectoscab

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Permethrin
Permethrin is a substance that kills lice and scabies mites when applied to the skin or hair.
Permethrin (25:75)
Permethrin is a topical substance that kills lice and mites, used to treat head lice and scabies.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Infectomite
Infectoperm
Loxazol

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Thermalsole und Schwefelbad Bentheim GmbH
Klinik für Dermatologie
Bad Bentheim, Germany
Klinikum Dortmund gGmbH
Klinik für Dermatologie und Venerologie
Dortmund, Germany
HELIOS Klinikum Duisburg GmbH
Klinik für Dermatologie, Venerologie und Allergologie
Duisburg, Germany

Sponsor: INFECTOPHARM Arzneimittel und Consilium GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.